Search clinical trials for: CHF

Total 457 results

University of Florida

Completed

RAAS Optimization for Acute CHF Patients (ROAD-HF)

Acute Decompensated Heart Failure

United States
Chiesi Farmaceutici S.p.A.

Completed

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD) (TRI-D)

Chronic Obstructive Pulmonary Disease

Bulgaria
Chiesi Farmaceutici S.p.A.

Completed

TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER) (TRIGGER)

Asthma

Argentina, Belarus, Bulgaria, Czechia, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine, United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Triple in Asthma Dose Finding (Triskel)

Asthma

Bulgaria, Germany, Hungary, Italy, Poland, United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA (TRIMARAN)

Asthma

Germany
Chiesi Farmaceutici S.p.A.

Completed

Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA)

Asthma

Bulgaria, Germany, Italy, Netherlands, Poland
Chiesi Farmaceutici S.p.A.

Completed

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

COPD (Chronic Obstructive Pulmonary Disease)

China, Korea, Republic of, Taiwan
Chiesi Farmaceutici S.p.A.

Completed

A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis

Cystic Fibrosis | Non-Cystic Fibrosis Bronchiectasis

Germany
Sequana Medical N.V.

Withdrawn

Optimal Balance Alfapump® System Feasibility Study (OPTIMALBALANCE)

Heart Failure

Hungary
University of Maryland, Baltimore
Biosense Webster, Inc.

Terminated

Early Elimination of Premature Ventricular Contractions in Heart Failure (EVAC-HF)

Congestive Heart Failure | Premature Ventricular Contractions

United States, Canada
Yaounde Central Hospital

Enrolling by invitation

Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon (CARECA-CHF)

Chronic Heart Failure (CHF)

Cameroon
Novartis Pharmaceuticals

Completed

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care (PREFER)

Chronic Heart Failure (CHF)

Croatia, Russian Federation, Belgium, Slovenia, Spain, Lithuania, Estonia, Hungary, France, Latvia, Norway, Cyprus, Denmark, Israel, Italy, Malta, Poland, Portugal
Heart Care Foundation

Completed

Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study

Heart Failure

Italy
Seattle Institute for Biomedical and Clinical Research
United States Department of Defense; VA Puget Sound Health Care System

Completed

Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders (PaN)

Alcohol Use Disorder | Posttraumatic Stress Disorder (PTSD)

United States
Novartis Pharmaceuticals

Completed

Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)

Chronic Heart Failure (CHF)

Netherlands, Germany, Poland, United States
Novartis Pharmaceuticals

Completed

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

Type II Diabetes Mellitus | Congestive Heart Failure

Russian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland
Assistance Publique - Hôpitaux de Paris

Unknown

Dietetics Education Focused on Malnutrition Prevention (NUTRICOEUR)

Chronic Heart Failure (CHF)

France
Massachusetts General Hospital

Unknown

A Trial of a CPR Video in Heart Failure Patients

Congestive Heart Failure

United States
Theranova, L.L.C.

Completed

Treatment Parameters for the Empower Neuromodulation System (ENS) (AUD1)

Alcohol Use Disorder

United States
Massachusetts General Hospital
University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Unknown

Using Videos to Facilitate Advance Care Planning for Patients With Heart Failure (VIDEO-HF)

CHF

United States
Tomsk National Research Medical Center of the Russian...

Completed

SPECT-based Prediction and Evaluation of CRT Efficacy in CHF (MIBGinCRT)

Chronic Heart Failure

Russian Federation
Chiesi Farmaceutici S.p.A.
SGS S.A.

Completed

Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD

COPD

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old (PAED1)

Asthma

Denmark
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 (CHF6001Ext)

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients. (ADONE)

Asthma

United Kingdom, Denmark
Chiesi Farmaceutici S.p.A.

Completed

Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients (ADO pMDI)

Asthma

Poland
Chiesi Farmaceutici S.p.A.

Completed

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI

Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome

Respiratory Distress Syndrome in Premature Infants

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old (PAED4)

Asthma in Children

Denmark
Chiesi Farmaceutici S.p.A.

Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD (GlycoNEXT)

Chronic Obstructive Pulmonary Disease (COPD)

Czechia, Germany, Hungary, Romania
Chiesi Farmaceutici S.p.A.

Completed

PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

Asthma

Belgium
Assiut University

Unknown

Frequency and Risk Factors of Congestive Heart Failure in Dialysis Patients

Congestive Heart Failure
Riverside University Health System Medical Center

Unknown

Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?

Acute Decompensated Heart Failure

United States
Fondazione Don Carlo Gnocchi Onlus
University of Milano Bicocca; Università Carlo Cattaneo , Castellanza

Unknown

An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B) (SIDERA^B)

Chronic Obstructive Pulmonary Disease (COPD) | Chronic Heart Failure (CHF) | Parkinson Disease (PD)

Italy
University of Alabama at Birmingham
National Palliative Care Research Center (NPCRC)

Completed

ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

Heart Failure, Congestive

United States
Chiesi Farmaceutici S.p.A.

Completed

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Terminated

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD (CHF6297 FIH)

Chronic Obstructive Pulmonary Disease

United Kingdom
Yale University
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Tele-HF: Yale Heart Failure Telemonitoring Study

Congestive Heart Failure

United States
National Heart Centre Singapore
National University Hospital, Singapore; Khoo Teck Puat Hospital; Singapore General... and other collaborators

Active, not recruiting

Singapore Cardiac Longitudinal Outcomes Database (SingCLOUD)

Coronary Artery Disease | Atrial Fibrillation | Congestive Heart Failure

Singapore
Children's Hospital of Fudan University

Completed

Effect of Reduced Noise Levels and Cycled Light on Visual and Neural Development in Preterm Infants

Preterm Infants

China
Prof. Dr. Mehdi Zoghi

Withdrawn

Heart Failure Management in Azerbaijan (CHF-AZ)

Heart Failure

Azerbaijan
Mayron Faria de Oliveira
Coordination for the Improvement of Higher Education Personnel

Completed

Heart Failure Worsens Muscle Strength in COPD

Muscle Weakness | COPD | CHF
University of Pennsylvania

Completed

Developing Enhanced Prediction Models (PREDICT)

Pneumonia | Diabetes | Chronic Obstructive Pulmonary Disease (COPD) | Congestive Heart Failure (CHF) | Acute Myocardial Infraction or Chest Pain

United States
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Terminated

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants (Biso-CHF)

Heart Failure

China
Mayo Clinic
National Institutes of Health (NIH)

Completed

Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction (Aim 3 BNP/PDEV)

Heart Failure | Renal Dysfunction
Impulse Dynamics

Completed

Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System (FIX-HF-5C2)

Heart Failure | Congestive Heart Failure | CHF | Chronic Heart Disease

United States, Germany
CN NGANOU-GNINDJIO, MD, MSc

Completed

Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study (ERADAL-HF)

Iron Deficiency | Chronic Heart Failure (CHF)

Cameroon
CardioCell LLC
Stemedica Cell Technologies, Inc.

Completed

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Non-Ischemic Heart Failure

United States
University of Leeds

Completed

The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients. (TREPPE)

Atrial Fibrillation | Chronic Heart Failure | Arrhythmia, Sinus

United Kingdom

Search clinical trials for: CHF

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations